CMOs
Apr 01, 2015
Antibody-Drug Conjugate and Big Pharmaceutical Companies
Antibody Drug Conjugate and Big Pharmaceutical Companies Boom Antibody-drug conjugates is gaining popularity in the Biopharmaceutical industries. As Initial trials with these targeted treatments show success, more companies are looking to produce these drugs. Although antibody-drug conjugates show promise in the d...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
